Reyes Financial Architecture’s iShares Biotechnology ETF IBB Stock Holding History

Reyes Financial Architecture’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1M	Buy	+52,885	New	+$9.09M	5.63%	4
2026 Q1	–	Sell	-730	Closed	-$123K	–	391
2025 Q4	$123K	Hold	730	–	–	0.08%	97
2025 Q3	$105K	Buy	+730	New	+$99.6K	0.07%	118
2025 Q2	–	Sell	-45	Closed	-$5.76K	–	309
2025 Q1	$5.76K	Hold	45	–	–	﹤0.01%	257
2024 Q4	$5.95K	Buy	+45	New	+$6.33K	﹤0.01%	230

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Reyes Financial Architecture's IBB Position: Q2 2026 in Review

Reyes Financial Architecture opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 52,885 shares worth $10.1M. The stake represents 5.63% of the portfolio and ranks #4 among its holdings. This is a return to the name: Reyes Financial Architecture previously reported a position in IBB as recently as Q4 2025.

Reyes Financial Architecture first reported a position in IBB in Q4 2024 and has held it in 5 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Reyes Financial Architecture held 52,885 shares of iShares Biotechnology ETF worth $10.1M as of Q2 2026.
iShares Biotechnology ETF was a new Reyes Financial Architecture position in Q2 2026.
iShares Biotechnology ETF made up 5.63% of Reyes Financial Architecture's portfolio in Q2 2026, its #4 holding.
Reyes Financial Architecture first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 5 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Reyes Financial Architecture's 13F filing for Q2 2026, filed 17 Jul 2026.